We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Protocol Rapidly Detects Three Legionella Species

By LabMedica International staff writers
Posted on 01 Mar 2016
An innovative protocol has been developed for the detection of the three most prevalent Legionella species, enabling the source of the infection to be located in just eight hours.

The genus Legionella is a pathogenic group of Gram-negative bacteria that includes the species L. pneumophila, causing legionellosis and illnesses caused by Legionella include a pneumonia-type illness called Legionnaires' disease and a mild flu-like illness called Pontiac fever.

Scientists at the Polytechnic University of Valencia (UPV; Spain) initially based their investigation on a study carried out by a Japanese research group aiming to detect as many as four Legionella species simultaneously. However, the UPV team found that this approach was not viable and began devising a protocol for just three species: L. pneumophila (the bacteria responsible for 90% of human Legionella cases, L. micdadei and L. longbeachae. The protocol is considered a breakthrough that relies on the combined use of a multiplex polymerase chain reaction (Multiplex PCR) and pretreatment with propidium monoazide (PMA).

The new protocol brings detection time down from 14 days to just eight hours, which is a marked improvement on the most commonly used detection method. It can also be used successfully in very contaminated samples, where existing methods cannot. Yolanda Moreno Trigo, PhD, the senior scientist on the project, said, “We concentrated the sample, broke the bacteria in order to extract its DNA and then used Multiplex PCR to identify the different Legionella species. The Multiplex PCR amplifies the DNA of the target species, making it easier to identify them. Pretreatment with PMA allows us to immediately discard the DNA of the dead cells, which we are not interested in.”

Related Links:

Polytechnic University of Valencia 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)

New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results

Respiratory tract infections are a major reason for emergency department visits and hospitalizations. According to the CDC, the U.S. sees up to 41 million influenza cases annually, resulting in several... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.